Pediatrics & Clinical Trials
ICON Pediatrics Team & CISCRP Present
2 Flash Webinars
15-MINUTE FLASH WEBINAR 1
15-MINUTE FLASH WEBINAR 2
Adolescents in Clinical Trials &
the RACE for Children Act
Advocating for Yourself or Your Child
in a Clinical Trial
Wednesday, August 25th, 12:00PM – 12:15PM EST
Missy Hansen, MSN, APRN, CPNP, CPHON, Pediatric Strategy Liaison, Center for Pediatric Clinical Development, ICON a former nurse practitioner now working in pediatric clinical development, and Lori Ranney, DNP, APRN, CPNP, CPHON, Children’s Minnesota, a nurse practitioner, will discuss the future of pediatric oncology development and treatment options and their experiences treating the adolescent and young adult populations in light of the passage of the RACE (Research to Accelerate Cures & Equity) for Children Act.
Wednesday, September 22nd, 12:00PM – 12:15PM EST
Dr. Mark Sorrentino, MD, MS, Vice President, Center for Pediatric Development, ICON, and Dr. Joanna L. Perkins, MD, MS, Director of Medical Affairs, Hematology-Oncology, Americas, ICON, will discuss how to advocate for yourself or your child in a clinical trial. Dr. Sorrentino brings his perspective as a clinical study participant and Dr. Perkins will expand on her experience from an investigator’s lens.
Missy Hansen, MSN, APRN, CPNP, CPHON, Pediatric Strategy Liaison, Center for Pediatric Clinical Development, ICON
Missy Hansen MSN, APRN, CPNP, CPHON, joined ICON in 2019 as a pediatric strategy liaison. She has 25+ years of experience as a pediatric nurse practitioner, including 17+ years in pediatric hematology/oncology at Children’s Minnesota, the largest hematology/oncology service line in the region, providing care for infants through young adults diagnosed with hematologic and/or oncology conditions. Ms. Hansen gained expertise working in inpatient, outpatient, and urgent care type settings. Ms. Hansen has in-depth experience working with the Children’s Oncology Group—the largest consortium with the most open pediatric studies around the world. She also has experience working with other consortia that conduct trials for pediatric to young adult patients.
Mark Sorrentino, MD, MS, Vice President, Center for Pediatric Clinical Development, ICON
Mark has over 20 years of experience in the pharmaceutical and biotech industries and currently leads ICON’s global pediatric center of excellence. Having earned his medical degree and master's degree in clinical nutrition from the Chicago Medical School, Dr. Sorrentino completed both a residency in pediatrics and a fellowship in pediatric critical care at Children's National Medical Center (CNMC) in Washington, DC. Currently, Dr. Sorrentino holds an appointment as an assistant clinical professor at the George Washington University School of Medicine. Prior to joining the industry, Dr. Sorrentino was an attending physician in the CNMC pediatric intensive care unit for 8 years and participated in numerous industry-sponsored critical care trials. He holds active medical licenses in California and Maryland.
Lori Ranney, DNP, APRN, CPNP, CPHON, Children's Minnesota
Lori Ranney DNP, APRN, CPNP, CPHON has worked in pediatric oncology for 20 years and has been a PNP at Children's Minnesota for over 13 years. She has a special interest in leukemia/lymphoma, patient/family education, AYA population, and oncofertility. She is a member of the Children’s Oncology Group and has actively enrolled patients in clinical trials for over 15 years.
Joanna L. Perkins, MD, MS, Director of Medical Affairs, Hematology-Oncology, Americas, ICON
Based in Minnesota, Dr. Perkins has 21 years of experience in clinical research across Phases I–III with a focus on hematologic malignancies. Before joining ICON in 2018, she was in clinical practice for 15 years specializing in leukemias, lymphomas, and long-term complications of cancer therapy. Dr. Perkins has supported multiple oncology/hematology trials across indications and phases. She is board certified in pediatrics and pediatric hematology and oncology and holds a master's degree in clinical research.